Trial intelligence / Profile preview

Ozurdex for Hard Exudates in Diabetic Macular Edema

NCT02399657Phase 4Unknown

Sponsor
Inje University
Start
Feb 2015
Primary completion
Dec 2016
Countries
1
01

Overview

A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by Inje University. Status: unknown.

02

Drugs

ozurdex
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT02399657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02399657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call